{"transactions":[{"id":1903979,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class B Common Stock","published_at":"2023-05-05T00:18:43.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Includes shares of Class B Common Stock that are subject to vesting conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."}],"balance_after":50612,"derivative":{"underlying":"Class A Common Stock","underlying_shares":307},"source":{"system":"sec-edgar","filing":"0001127602-23-014600","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223014600/form4.xml","form_type":"4"}},{"id":1903978,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-05-05T00:18:43.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in 48 equal monthly installments, which began on April 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in 48 equal monthly installments, which began on April 1, 2023."}],"balance_after":172500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001127602-23-014600","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223014600/form4.xml","form_type":"4"}},{"id":1903977,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-05-05T00:18:43.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":false,"shares":13683,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":357645,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13683},"source":{"system":"sec-edgar","filing":"0001127602-23-014600","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223014600/form4.xml","form_type":"4"}},{"id":1903976,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-05T00:18:43.000Z","date":"2023-05-02","kind":"sale","planned":false,"acquired":false,"shares":8073,"price":1.147,"value":9259.731,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":183010,"source":{"system":"sec-edgar","filing":"0001127602-23-014600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223014600/form4.xml","form_type":"4"}},{"id":1903975,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-05T00:18:43.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."}],"balance_after":191083,"source":{"system":"sec-edgar","filing":"0001127602-23-014600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223014600/form4.xml","form_type":"4"}},{"id":1903974,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-05T00:18:43.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":190776,"source":{"system":"sec-edgar","filing":"0001127602-23-014600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223014600/form4.xml","form_type":"4"}},{"id":1903973,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-05-05T00:18:43.000Z","date":"2023-05-01","kind":"exercise","planned":false,"acquired":true,"shares":13683,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":187026,"source":{"system":"sec-edgar","filing":"0001127602-23-014600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223014600/form4.xml","form_type":"4"}},{"id":1924451,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class B Common Stock","published_at":"2023-04-05T22:38:44.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Includes shares of Class B Common Stock that are subject to vesting conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."}],"balance_after":50919,"derivative":{"underlying":"Class A Common Stock","underlying_shares":307},"source":{"system":"sec-edgar","filing":"0001127602-23-012625","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012625/form4.xml","form_type":"4"}},{"id":1924450,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T22:38:44.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest in 48 equal monthly installments, which began on April 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest in 48 equal monthly installments, which began on April 1, 2023."}],"balance_after":176250,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001127602-23-012625","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012625/form4.xml","form_type":"4"}},{"id":1924449,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T22:38:44.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":13684,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on April 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on April 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on April 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on April 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on April 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":371328,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13684},"source":{"system":"sec-edgar","filing":"0001127602-23-012625","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012625/form4.xml","form_type":"4"}},{"id":1924448,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-05T22:38:44.000Z","date":"2023-04-03","kind":"sale","planned":false,"acquired":false,"shares":8732,"price":1.269,"value":11080.908,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":173343,"source":{"system":"sec-edgar","filing":"0001127602-23-012625","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012625/form4.xml","form_type":"4"}},{"id":1924447,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-05T22:38:44.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."}],"balance_after":182075,"source":{"system":"sec-edgar","filing":"0001127602-23-012625","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012625/form4.xml","form_type":"4"}},{"id":1924446,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-05T22:38:44.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."}],"balance_after":181768,"source":{"system":"sec-edgar","filing":"0001127602-23-012625","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012625/form4.xml","form_type":"4"}},{"id":1924445,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-04-05T22:38:44.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":13684,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on April 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on April 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":178018,"source":{"system":"sec-edgar","filing":"0001127602-23-012625","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223012625/form4.xml","form_type":"4"}},{"id":1938869,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-03-24T21:13:14.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":180000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in 48 equal monthly installments beginning on April 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in 48 equal monthly installments beginning on April 1, 2023."}],"balance_after":180000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001127602-23-011321","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223011321/form4.xml","form_type":"4"}},{"id":1971059,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class B Common Stock","published_at":"2023-03-03T22:15:42.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes shares of Class B Common Stock that are subject to vesting conditions."}],"balance_after":51226,"derivative":{"underlying":"Class A Common Stock","underlying_shares":307},"source":{"system":"sec-edgar","filing":"0001127602-23-008805","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223008805/form4.xml","form_type":"4"}},{"id":1971058,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-03-03T22:15:42.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":13683,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,683 of the RSUs was satisfied on March 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,683 of the RSUs was satisfied on March 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,683 of the RSUs was satisfied on March 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,683 of the RSUs was satisfied on March 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,683 of the RSUs was satisfied on March 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":385012,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13683},"source":{"system":"sec-edgar","filing":"0001127602-23-008805","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223008805/form4.xml","form_type":"4"}},{"id":1971057,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:15:42.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":7326,"price":1.329,"value":9736.254,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":164334,"source":{"system":"sec-edgar","filing":"0001127602-23-008805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223008805/form4.xml","form_type":"4"}},{"id":1971056,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:15:42.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."}],"balance_after":171660,"source":{"system":"sec-edgar","filing":"0001127602-23-008805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223008805/form4.xml","form_type":"4"}},{"id":1971055,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:15:42.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":13683,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,683 of the RSUs was satisfied on March 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,683 of the RSUs was satisfied on March 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":171353,"source":{"system":"sec-edgar","filing":"0001127602-23-008805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223008805/form4.xml","form_type":"4"}},{"id":2031798,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class B Common Stock","published_at":"2023-02-03T22:20:47.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":306,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes shares of Class B Common Stock that are subject to vesting conditions."}],"balance_after":51533,"derivative":{"underlying":"Class A Common Stock","underlying_shares":306},"source":{"system":"sec-edgar","filing":"0001127602-23-003407","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223003407/form4.xml","form_type":"4"}},{"id":2031797,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-03T22:20:47.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":13684,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on February 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on February 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on February 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on February 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on February 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":398695,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13684},"source":{"system":"sec-edgar","filing":"0001127602-23-003407","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223003407/form4.xml","form_type":"4"}},{"id":2031796,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-02-03T22:20:47.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":6470,"price":2.149,"value":13904.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":157670,"source":{"system":"sec-edgar","filing":"0001127602-23-003407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223003407/form4.xml","form_type":"4"}},{"id":2031795,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-02-03T22:20:47.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."}],"balance_after":164140,"source":{"system":"sec-edgar","filing":"0001127602-23-003407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223003407/form4.xml","form_type":"4"}},{"id":2031794,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-02-03T22:20:47.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":13684,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on February 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,684 of the RSUs was satisfied on February 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":163834,"source":{"system":"sec-edgar","filing":"0001127602-23-003407","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223003407/form4.xml","form_type":"4"}},{"id":2059771,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class B Common Stock","published_at":"2023-01-06T23:27:34.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes shares of Class B Common Stock that are subject to vesting conditions."}],"balance_after":51839,"derivative":{"underlying":"Class A Common Stock","underlying_shares":307},"source":{"system":"sec-edgar","filing":"0001127602-23-001108","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223001108/form4.xml","form_type":"4"}},{"id":2059770,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2023-01-06T23:27:34.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":15350,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 15,350 of the RSUs was satisfied on January 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 15,350 of the RSUs was satisfied on January 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 15,350 of the RSUs was satisfied on January 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 15,350 of the RSUs was satisfied on January 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 15,350 of the RSUs was satisfied on January 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":412379,"derivative":{"underlying":"Class A Common Stock","underlying_shares":15350},"source":{"system":"sec-edgar","filing":"0001127602-23-001108","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223001108/form4.xml","form_type":"4"}},{"id":2059769,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-01-06T23:27:34.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":7900,"price":1.556,"value":12292.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a \"sell to cover\" transaction."}],"balance_after":150150,"source":{"system":"sec-edgar","filing":"0001127602-23-001108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223001108/form4.xml","form_type":"4"}},{"id":2059768,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-01-06T23:27:34.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."}],"balance_after":158050,"source":{"system":"sec-edgar","filing":"0001127602-23-001108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223001108/form4.xml","form_type":"4"}},{"id":2059767,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"officer":true,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2023-01-06T23:27:34.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":15350,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 15,350 of the RSUs was satisfied on January 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 15,350 of the RSUs was satisfied on January 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":157743,"source":{"system":"sec-edgar","filing":"0001127602-23-001108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000112760223001108/form4.xml","form_type":"4"}},{"id":2095400,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class B Common Stock","published_at":"2022-12-06T02:16:25.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes shares of Class B Common Stock that are subject to vesting conditions."}],"balance_after":52146,"derivative":{"underlying":"Class A Common Stock","underlying_shares":307},"source":{"system":"sec-edgar","filing":"0000899243-22-037732","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322037732/doc4.xml","form_type":"4"}},{"id":2095399,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2022-12-06T02:16:25.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":13350,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on December 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on December 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on December 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on December 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":427729,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13350},"source":{"system":"sec-edgar","filing":"0000899243-22-037732","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322037732/doc4.xml","form_type":"4"}},{"id":2095398,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2022-12-06T02:16:25.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":6176,"price":1.943,"value":11999.968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of securities. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligation to be funded by a \"sell to cover\" transaction."}],"balance_after":142393,"source":{"system":"sec-edgar","filing":"0000899243-22-037732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322037732/doc4.xml","form_type":"4"}},{"id":2095397,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2022-12-06T02:16:25.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."}],"balance_after":148569,"source":{"system":"sec-edgar","filing":"0000899243-22-037732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322037732/doc4.xml","form_type":"4"}},{"id":2095396,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2022-12-06T02:16:25.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":13350,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on December 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on December 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":148262,"source":{"system":"sec-edgar","filing":"0000899243-22-037732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322037732/doc4.xml","form_type":"4"}},{"id":2123161,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class B Common Stock","published_at":"2022-11-08T02:35:32.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes shares of Class B Common Stock that are subject to vesting conditions."}],"balance_after":52453,"derivative":{"underlying":"Class A Common Stock","underlying_shares":307},"source":{"system":"sec-edgar","filing":"0000899243-22-035327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322035327/doc4.xml","form_type":"4"}},{"id":2123160,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2022-11-08T02:35:32.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":13350,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on November 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on November 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on November 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on November 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"On October 7, 2022, the Reporting Person filed a Form 4 that reported holdings of 442,161 RSUs. At that time the Reporting Person held 454,429 RSUs."}],"balance_after":441079,"derivative":{"underlying":"Class A Common Stock","underlying_shares":13350},"source":{"system":"sec-edgar","filing":"0000899243-22-035327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322035327/doc4.xml","form_type":"4"}},{"id":2123159,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2022-11-08T02:35:32.000Z","date":"2022-11-03","kind":"sale","acquired":false,"shares":6279,"price":2.645,"value":16607.955,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of securities. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligation to be funded by a \"sell to cover\" transaction."}],"balance_after":134912,"source":{"system":"sec-edgar","filing":"0000899243-22-035327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322035327/doc4.xml","form_type":"4"}},{"id":2123158,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2022-11-08T02:35:32.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":307,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."}],"balance_after":141191,"source":{"system":"sec-edgar","filing":"0000899243-22-035327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322035327/doc4.xml","form_type":"4"}},{"id":2123157,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2022-11-08T02:35:32.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":13350,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on November 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 13,350 of the RSUs was satisfied on November 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":140884,"source":{"system":"sec-edgar","filing":"0000899243-22-035327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322035327/doc4.xml","form_type":"4"}},{"id":2140016,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2022-10-08T00:21:10.000Z","date":"2022-10-06","kind":"sale","acquired":false,"shares":102254,"price":3.25,"value":332325.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligation to be funded by a \"sell to cover\" transaction."}],"balance_after":127534,"source":{"system":"sec-edgar","filing":"0000899243-22-033326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322033326/doc4.xml","form_type":"4"}},{"id":2140015,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2022-10-08T00:19:53.000Z","date":"2022-10-01","kind":"exercise","acquired":false,"shares":226376,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes RSUs that are subject to vesting conditions. Includes 190,000 RSUs that were acquired after November 17, 2021."}],"balance_after":442161,"derivative":{"underlying":"Class A Common Stock"},"source":{"system":"sec-edgar","filing":"0000899243-22-033325","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322033325/doc4a.xml","form_type":"4/A","original_submission_date":"2022-10-04"}},{"id":2140014,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2022-10-08T00:19:53.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":490805,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes RSUs that are subject to vesting conditions. Includes 190,000 RSUs that were acquired after November 17, 2021."}],"balance_after":680805,"derivative":{"underlying":"Class A Common Stock"},"source":{"system":"sec-edgar","filing":"0000899243-22-033325","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322033325/doc4a.xml","form_type":"4/A","original_submission_date":"2022-10-04"}},{"id":2140013,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class B Common Stock","published_at":"2022-10-08T00:19:53.000Z","date":"2022-09-30","kind":"exercise","acquired":false,"shares":6134,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes shares of Class B Common Stock that are subject to vesting conditions. Excludes RSUs, which were previously reported as shares of Class B Common Stock on the Form 4 filed by the reporting person on March 14, 2022.  Because the Issuer has the ability to settle such RSUs with shares of Class A Common Stock or cash upon vesting, RSUs will be reported separately from shares of Class B Common Stock in future reports."}],"balance_after":52760,"derivative":{"underlying":"Class A Common Stock"},"source":{"system":"sec-edgar","filing":"0000899243-22-033325","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322033325/doc4a.xml","form_type":"4/A","original_submission_date":"2022-10-04"}},{"id":2140012,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2022-10-08T00:19:53.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":2722,"price":3.1216,"value":8496.9952,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.  Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligation to be funded by a \"sell to cover\" transaction."}],"balance_after":229788,"source":{"system":"sec-edgar","filing":"0000899243-22-033325","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322033325/doc4a.xml","form_type":"4/A","original_submission_date":"2022-10-04"}},{"id":2140011,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2022-10-08T00:19:53.000Z","date":"2022-10-01","kind":"exercise","acquired":true,"shares":226376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition with respect to 226,376 of the RSUs was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":232510,"source":{"system":"sec-edgar","filing":"0000899243-22-033325","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322033325/doc4a.xml","form_type":"4/A","original_submission_date":"2022-10-04"}},{"id":2140010,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Class A Common Stock","published_at":"2022-10-08T00:19:53.000Z","date":"2022-09-30","kind":"exercise","acquired":true,"shares":6134,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."}],"balance_after":6134,"source":{"system":"sec-edgar","filing":"0000899243-22-033325","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322033325/doc4a.xml","form_type":"4/A","original_submission_date":"2022-10-04"}},{"id":2143449,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-10-05T02:05:19.000Z","date":"2022-10-01","kind":"exercise","acquired":false,"shares":490805,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes restricted stock units that are subject to vesting conditions. Includes 190,000 restricted stock units that were acquired after November 17, 2021."}],"balance_after":190000,"derivative":{"underlying":"Class A Common Stock"},"source":{"system":"sec-edgar","filing":"0000899243-22-032863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322032863/doc4.xml","form_type":"4"}},{"id":2143448,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-10-05T02:05:19.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":490805,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes restricted stock units that are subject to vesting conditions. Includes 190,000 restricted stock units that were acquired after November 17, 2021."}],"balance_after":680805,"derivative":{"underlying":"Class A Common Stock"},"source":{"system":"sec-edgar","filing":"0000899243-22-032863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322032863/doc4.xml","form_type":"4"}},{"id":2143447,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class B Common Stock","published_at":"2022-10-05T02:05:19.000Z","date":"2022-09-30","kind":"exercise","acquired":false,"shares":6134,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes shares of Class B Common Stock that are subject to vesting conditions."}],"balance_after":52760,"derivative":{"underlying":"Class A Common Stock"},"source":{"system":"sec-edgar","filing":"0000899243-22-032863","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322032863/doc4.xml","form_type":"4"}},{"id":2143446,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2022-10-05T02:05:19.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":2722,"price":3.1216,"value":8496.9952,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.  Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligation to be funded by a \"sell to cover\" transaction."}],"balance_after":494217,"source":{"system":"sec-edgar","filing":"0000899243-22-032863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322032863/doc4.xml","form_type":"4"}},{"id":2143445,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2022-10-05T02:05:19.000Z","date":"2021-10-01","kind":"exercise","acquired":true,"shares":490805,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents restricted stock units (the \"RSUs\") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the \"Merger\"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition.  On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022.   The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU.  Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person."}],"balance_after":496939,"source":{"system":"sec-edgar","filing":"0000899243-22-032863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322032863/doc4.xml","form_type":"4"}},{"id":2143444,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2022-10-05T02:05:19.000Z","date":"2022-09-30","kind":"exercise","acquired":true,"shares":6134,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."}],"balance_after":6134,"source":{"system":"sec-edgar","filing":"0000899243-22-032863","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322032863/doc4.xml","form_type":"4"}},{"id":2334763,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class B Common Stock","published_at":"2022-03-15T01:32:02.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents an award of restricted stock units covering Class B Common Stock, which vests in 48 equal monthly installments following the vesting commencement date of March 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents an award of restricted stock units covering Class B Common Stock, which vests in 48 equal monthly installments following the vesting commencement date of March 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 40,000 restricted stock units covering Class B Common Stock that were previously reported as Restricted Stock Units on the Form 4 filed by the reporting person on January 26, 2022. The reporting person intends to report such restricted stock units on a consolidated basis with her holdings of the underlying Class B Common Stock in future reports."}],"balance_after":248894,"derivative":{"underlying":"Class A Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-22-010984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322010984/doc4.xml","form_type":"4"}},{"id":2424837,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-01-26T23:42:11.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Class B Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: 5% of the underlying shares on January 1, 2023; 12 monthly installments of 0.83% of the underlying shares thereafter; 12 monthly installments of 1.25% of the underlying shares thereafter; 24 monthly installments of 1.67% of the underlying shares thereafter; and 12 monthly installments of 2.5% of the underlying shares thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: 5% of the underlying shares on January 1, 2023; 12 monthly installments of 0.83% of the underlying shares thereafter; 12 monthly installments of 1.25% of the underlying shares thereafter; 24 monthly installments of 1.67% of the underlying shares thereafter; and 12 monthly installments of 2.5% of the underlying shares thereafter."}],"balance_after":40000,"derivative":{"underlying":"Class B Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-22-003308","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924322003308/doc4.xml","form_type":"4"}},{"id":2563606,"issuer":{"id":5530,"kind":"organization","name":"Ginkgo Bioworks Holdings, Inc.","symbol":"DNA"},"owners":[{"id":113856,"kind":"person","name":"Fallon Marie E.","position":1,"cik":"0001883686","reported_name":"Fallon Marie E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Class B Common Stock","published_at":"2021-09-21T01:48:08.000Z","date":"2021-09-16","kind":"grant","acquired":true,"shares":58894,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. (\"Legacy Ginkgo\"), as contemplated by an agreement and plan of merger, dated May 11, 2021 as amended on May 14, 2021 (the \"Merger Agreement\"), each share of Class A common stock of Legacy Ginkgo, each share of Class B common stock of Legacy Ginkgo, each option of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, each award of restricted common stock of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, and each award of restricted stock units of Legacy Ginkgo under Legacy Ginkgo's stock incentive plans, in each case outstanding immediately prior to the effective time of the business combination, received a proportional amount of the approximately 188.7 million earn-out shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects earn-out shares that will vest in four substantially equal installments if the Issuer's Class A Common Stock achieves a price per share for any period of 20 trading days out of 30 consecutive trading days prior to September 16, 2026 that equals or exceeds the following thresholds: $12.50, $15.00, $17.50 and $20.00."}],"balance_after":58894,"derivative":{"underlying":"Class A Common Stock","underlying_shares":58894},"source":{"system":"sec-edgar","filing":"0000899243-21-036682","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1830214/000089924321036682/doc4.xml","form_type":"4"}}]}